ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,978Medicare Part D Prescriptions Filled, Including Refills

Rank: 124 out of 944

$561K Total Retail Price of All Prescriptions

Rank: 154 out of 944

442 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
62% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Wisconsin
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 442 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

5% of this provider’s 442 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

0% of this provider’s 9,895 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Wisconsin
WARFARIN SODIUM 549 542 1 7
LOVASTATIN 505 426 2 26
LISINOPRIL 419 362 3 3
AMLODIPINE BESYLATE 416 382 4 5
METOPROLOL TARTRATE 361 344 5 8
FUROSEMIDE 342 311 6 6
LEVOTHYROXINE SODIUM 324 291 7 2
CITALOPRAM HBR 300 280 8 19
OMEPRAZOLE 272 240 9 4
SIMVASTATIN 258 236 10 1
HYDROCHLOROTHIAZIDE 195 186 11 9
ALENDRONATE SODIUM 186 162 12 20
POTASSIUM CHLORIDE 176 175 13 15
METFORMIN HCL 165 124 14 12
GABAPENTIN 162 143 15 18
NAMENDA 148 148 16 37
METOPROLOL SUCCINATE 144 131 17 14
ALLOPURINOL 142 120 18 22
DONEPEZIL HCL 139 139 19 24
RANITIDINE HCL 139 127 19 42
GLIPIZIDE 134 112 21 51
ADVAIR DISKUS 134 106 21 31
TAMSULOSIN HCL 127 127 23 27
QUETIAPINE FUMARATE 114 114 24 69
MIRTAZAPINE 105 105 25 35
ATENOLOL 101 82 26 11
FLUTICASONE PROPIONATE 98 89 27 40
ATORVASTATIN CALCIUM 97 87 28 13
CLOPIDOGREL 97 97 28 36
LANTUS 97 79 28 46
ENALAPRIL MALEATE 92 89 31 43
TRAMADOL HCL 92 92 31 21
DIGOXIN 91 90 33 39
FENOFIBRATE 88 77 34 58
FLUOXETINE HCL 87 85 35 48
PREDNISONE 81 67 36 32
VENTOLIN HFA 75 53 37 116
PRAVASTATIN SODIUM 69 59 38 17
LIDODERM 68 68 39 73
ISOSORBIDE MONONITRATE ER 66 66 40 52
LOSARTAN POTASSIUM 65 54 41 16
DIVALPROEX SODIUM 65 64 41 85
PLAVIX 63 63 43 55
GEMFIBROZIL 62 52 44 72
NOVOLOG 60 60 45 93
LISINOPRIL-HYDROCHLOROTHIAZIDE 58 49 46 29
PAROXETINE HCL 56 49 47 64
TRAZODONE HCL 52 29 48 45
VENLAFAXINE HCL ER 50 48 49 84
DOXAZOSIN MESYLATE 50 45 49 60
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.